GLP1R and inflammatory bowel disease: In conclusion, our study demonstrates the critical role of GLP-1 in maintaining gut health and highlights the potential of engineered probiotics as a targeted therapeutic strategy for IBD and other conditions characterized by gut barrier dysfunction.